Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CEO’ operating in the Clinical Trials space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
David MacMurchy
Chief Executive Officer of Lightship
David MacMurchy is the Chief Executive Officer at Lightship.
Follow David MacMurchy:
About Lightship: Lightship is a provider of enterprise-level and direct-to-patient clinical research solutions for decentralized clinical trials.
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Ronan Cunningham
Founder and Chief Executive Officer of BrainWaveBank
Ronan has more than 20 years of experience in advanced engineering and product development. He was one of the founding members of ATA Engineering, an award-winning San Diego-based engineering company specializing in development of innovative hardware and software technologies for the aerospace and defence industries. His roles have included Director of Business Development and Director of New Technology Development. He is an Entrepreneur-in-Residence with the Northern Ireland Science Park. His expertise is in early stage technology development, innovation strategy, and technology commercialisation. He holds an MS in Aeronautics and Astronautics from MIT.
Follow Ronan Cunningham:
About BrainWaveBank, Cumulus Neuroscience: BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.
Olga Kubassova
Chief Executive Officer of IAG, Image Analysis Group
Olga Kubassova is the Founder and CEO at IAG, mage Analysis Group. Mathematician with 10+ years expertise in actively managing innovation in life science companies, asset positioning, strategy and capital rising. Extensive expertise and domain knowledge in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics. Olga is a renowned healthcare innovator and biotech investor, with passion for improving people’s health.
Follow Olga Kubassova:
About Analytics Ventures, Bio Capital Impact Fund, European Commission, IAG, Image Analysis Group: IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure.
Ibraheem Mahmood
CEO of DrugDev
Ibraheem Mahmood is the president and CEO of DrugDev.
Follow Ibraheem Mahmood:
About AMO Pharma, DrugDev: DrugDev is a cloud technology based solutions that enable better clinical trials.
James McIlroy
CEO of EnteroBiotix
James is the founder and CEO of EnteroBiotix, leading the company from its inception to where it is today. Alongside his duties at EnteroBiotix, he is a part-time NHS junior doctor. While studying medicine, he was awarded an Enterprise Fellowship by the Royal Society of Edinburgh and a Visiting Research Fellowship by United European Gastroenterology. In 2017, James was named as one of the Ten Outstanding Young People in Scotland by Junior Chamber International, Emerging Entrepreneur of the Year by Business Quarter and Young Pioneer of the Year by Herald Scotland.
Follow James McIlroy:
About EnteroBiotix, EthosBio, University of Aberdeen: EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Duncan Hall
Founder and CEO of Triumph Research Intelligence
Duncan has over fifteen years of consultancy experience, thirteen of which have been within clinical R&D in both CRO and Pharma businesses. Duncan started Triumph in 2002 with the aim of building a global business which would be focused in improving the delivery, quality and value of clinical systems. Duncan now takes a primarily strategic role in TRI, but still performs client delivery roles where possible.
Follow Duncan Hall:
About Triumph Research Intelligence: Triumph Research Intelligence is a risk-Based Monitoring Company.
Jonathan Allis
Co-Founder & CEO of Blue Earth Diagnostics
Jonathan Allis is the founding CEO of Blue Earth Diagnostics. Prior to this role, Jonathan was the General Manager for PET at GE Healthcare Life Sciences, and had global responsibility for GE Healthcare’s PET agent and PET synthesis platforms business. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc., Siemens Medical Solutions and Oxford Magnet Technology, in the UK, USA and Germany. Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in biochemistry from the University of Oxford.
Follow Jonathan Allis:
About Blue Earth Diagnostics: BlueEarth Diagnostics mission is to transform the clinical management of recurrent prostate cancer
Deborah O’Neil
Founder & CEO of NovaBiotics
Follow Deborah O’Neil:
About BEAM Alliance, NovaBiotics: NovaBiotics Ltd is a clinical-stage biotechnology company.
Henry Pinchbeck
Co-Founder and Chief Executive Officer of 3D LifePrints
Henry Pinchbeck is Co-Founder Chief Executive Officer of 3D LifePrints.
Follow Henry Pinchbeck:
About 3D LifePrints: 3D LifePrints is the leading provider of Medical 3D Printing products and services with a unique in-hospital embedded model
Tony Bowden
Chief Executive Officer of Helicon Health
Tony Bowden is the CEO at Helicon Health.
Follow Tony Bowden:
About Helicon Health: Helicon Health delivers digital healthcare to improve outcomes and reduce the cost of chronic disease.
Stuart Young
Chief Executive Officer of Panthera Biopartners
Follow Stuart Young:
About Panthera Biopartners: Panthera Biopartners helps pharmaceutical and contract research organizations to find the patient for clinical trials.
Anne Dickinson
Founder & Chief Executive Officer of Alcyomics
Follow Anne Dickinson:
About Alcyomics: Alcyomics is a UK based unique pre-clinical service provider non-artificial human skin explants for safety and efficacy assessment.
